“Nichi Glucan” and “Nichi BRITE” potentials will be presented at an academic conference in Osaka, Japan
19/4/2024
“Nichi Glucan” and “Nichi BRITE” potentials will be presented at an academic conference in Osaka, Japan
News
Discovery of a safe adjuvant to Duchenne Muscular Dystrophy – A journey of 14 years of passion, pursuits & perseverance.
27/11/2023
A curiosity driven sojourn, across disciplines in science, led to the discovery of a safe adjuvant hidden in a beta glucan giving hope to patients with muscular dystrophy; A story of ZeitenWende all along, blessed with good people, hopefully a modest contribution to humanity by connecting the dots.
Skeletal Muscle Fibrosis in MDX mice model of Duchenne Muscular Dystrophy ameliorated by Neu-REFIX
15/11/2023
Published in Scientific Reports, a nature portfolio journal 15 November 2023 Significant reduction of muscle f
Edogawa NICHE Prize lecture by Dr. John Craig Venter, geneticist and a pioneer in human genome research in Toronto
5/11/2023
Edogawa NICHE Prize 2020 lecture by Dr. John Craig Venter, geneticist and a pioneer in human genome research in Toronto
Edogawa NICHE Prize awardee Dr John Craig Venter to deliver the lecture in UHN Ajmera Transplant Center in University of Toronto
21/10/2023
Dr John Craig Venter to deliver the lecture in UHN Ajmera Transplant Center in University of Toronto
Neu REFIX beta glucans improving Multiple Sclerosis patients’ gut microbiome awarded as the best poster in 6th Microbiome Asia Conference in Tokyo 26~27 April 2023
1/5/2023
Neu REFIX beta glucans improving Multiple Sclerosis patients’ gut microbiome awarded as the best poster
World Parkinson’s Day Webinar & Nichi BRITE Beta glucan clinical study report
30/4/2023
Nichi BRITE Beta glucans yileding clinically encouraging outcome in a trial was presented in the webinar that commemorated World Parkinsons Day held on the 10th April 2023
Neu-REFIX clinical and pre-clinical study results presented at MDA Muscular Dystrophy Conference 2023 in Neurology Live
27/3/2023
Neurology Live, a clinical neurologists focused media portal has published GN Corporation’s presentation at the MDA on the Clinical trial results of Neu REFIX in Duchenne Muscular Dystrophy
Neu REFIX Research on Duchenne Muscular Dystrophy to be presented at Muscular Dystrophy Association Conference 2023
2/3/2023
GN Corporation will present the results of preclinical and clinical studies with neu REFIX (N-163), one of its
Press Release
Increased yield of Beta 1,3-1,6 glucans, produce of AFO-202 strain of Aureobasidium Pullulans, using improvised techniques by Japanese scientists
6/7/2023
Japanese scientists, research collaborators to Nichi-in Centre for Regenerative Medicine
Neu REFIX B-glucans improve Anti-aging Butyrate & gut microbiome
17/6/2023
Neu REFIX B-glucans improve Anti-aging Butyrate & gut microbiome
BEES-HAUS method yielding successful cell engraftment to prevent recurrence of urethral stricture confirmed; Manuscript published in Stem Cell Reviews and Reports
26/11/2022
Manuscript published in Stem Cell Reviews and Reports